about
Anti-platelet therapy: phosphodiesterase inhibitors.Proton-coupled electron-transfer mechanism for the radical scavenging activity of cardiovascular drug dipyridamolePDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER.Ischemic stroke followed by acute thrombocytopenia: a double iatrogenic whammy.Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replicationTherapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy.Mixed cerebrovascular disease and the future of stroke prevention.Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva.Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drugP2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic windowCurrent therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.Brain regulation of thrombosis and hemostasis: from theory to practice.The intelligent use of systemic glucocorticoids in rheumatoid arthritis.Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration.Exercise versus vasodilator stress limb perfusion imaging for the assessment of peripheral artery disease.Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cellsBiphasic increase of gap junction coupling induced by dipyridamole in the rat aortic A-10 vascular smooth muscle cell line.Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapy.Recombinant amphiphilic protein micelles for drug delivery.Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis.Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.Presumed hydrogen sulfide-mediated neurotoxicity after streptococcus anginosus group meningitis.Dipyridamole-induced headache and lower recurrence risk in secondary prevention of ischaemic stroke: a post hoc analysis.Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial.Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis.Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome.Genetic Understanding of Stroke Treatment: Potential Role for Phosphodiesterase Inhibitors.Dipyridamole intervention of breast cell carcinogenesis.
P2860
Q27687228-D5AA5496-6FF1-4DB0-B529-4756161A5163Q28480596-753E47F5-DF90-46F7-8FAB-AD761B1C16E9Q30987183-951983E7-E2DD-4C6A-A06E-3E13900E39BAQ33385757-AF83C873-801C-43A5-B03A-CA54B8FAD71AQ33566587-A5E98894-5B6D-4EF1-A920-79A8D4B3A8E0Q35565914-B36342DA-DB49-4D2C-9E99-8A5EA27CA55BQ36025087-61FE6E36-FBFB-4E00-ABD8-7793BD14C65EQ36197280-98DFC464-4080-40EE-8A95-F1C095B7CA73Q37036154-0D673BBE-1B92-4053-8F02-74014E5CCE17Q37207076-4EA54B66-6608-4D26-B4D3-757938C32A38Q37494937-D22B448A-690D-4C12-B75C-F6ABA35AD6C6Q37971308-8C16C007-B4FE-4510-A226-B260545F4B8DQ38042445-FBAF8799-CB68-48DC-B347-27BB9892005BQ38148437-8CF6B675-D3DB-4754-9E50-EADCF829F5BBQ38168952-F960A88A-18A2-4E5E-AB01-60836289C3DBQ38676937-6BC76815-757E-4910-AF26-D862473D1691Q38700884-D1F39048-4423-49B8-99C3-AC7CB3815FE9Q39066002-CACDB227-3D8A-439C-9702-8CC1FA790CB8Q39181980-B38A175A-AB10-43BD-878D-C0792B6BD69EQ39273755-C19FED9C-5266-4DC4-A424-2A4120372FF7Q39468785-19BA6A1E-A9DC-4485-802E-FC47F93CBEE1Q40049271-1B87ADE0-8593-4184-9892-639A829D4F45Q41718404-9BA4EEFD-2DC5-4BE2-A8ED-DA5352AA282AQ42166117-DA4DEEDA-6E16-4288-8F55-24BD561B6A36Q44263191-B9980683-B8EF-4F89-AFC9-F6739AC2E99AQ44857549-A7E33F5B-5BC3-4E34-A802-021D684600A5Q45861292-2B93654B-1EAF-492C-B738-2185E51665E7Q47105513-7A2B1B62-5EEA-4729-B565-8C075AAD09C1Q47642330-D0DF9E7F-96C3-4DA1-9193-4C28C6C2F695Q48093627-2A9BD6B8-9F8C-41A1-BD40-122C2ADEC7C4Q54476969-25F1415F-068A-4033-A5C7-761CDE8BB69B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Translational therapeutics of dipyridamole.
@en
Translational therapeutics of dipyridamole.
@nl
type
label
Translational therapeutics of dipyridamole.
@en
Translational therapeutics of dipyridamole.
@nl
prefLabel
Translational therapeutics of dipyridamole.
@en
Translational therapeutics of dipyridamole.
@nl
P2860
P1476
Translational therapeutics of dipyridamole.
@en
P2093
Hyung-Hwan Kim
James K Liao
P2860
P304
P356
10.1161/ATVBAHA.107.160226
P407
P577
2008-01-03T00:00:00Z